Gastrojejunal ulcer

Summary

Gastrojejunal ulcer (MONDO:0001155) is a disease and 1 clinical trial. A subtype of peptic ulcer disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gastrojejunal ulcer
Mondo ID	MONDO:0001155
DOID	DOID:10927
ICD-10-CM	K28, K28.0
ICD-11	491213123
SNOMED CT	4269005
UMLS	C1384631
MedGen	730503
Is cancer (heuristic)	no

Also known as: acute gastrojejunal ulcer with haemorrhage · acute gastrojejunal ulcer with haemorrhage and obstruction · acute gastrojejunal ulcer with haemorrhage and perforation · acute gastrojejunal ulcer with haemorrhage and perforation, with obstruction · acute gastrojejunal ulcer with hemorrhage · acute gastrojejunal ulcer with perforation, with obstruction · acute gastrojejunal ulcer without haemorrhage and without perforation · acute gastrojejunal ulcer without mention of haemorrhage or perforation, without mention of obstruction · acute gastrojejunal ulcer without mention of hemorrhage or perforation, without mention of obstruction · acute gastrojejunal ulcer, with hemorrhage, with obstruction · chronic gastrojejunal ulcer without haemorrhage and without perforation · chronic gastrojejunal ulcer without mention of haemorrhage or perforation, without mention of obstruction · chronic gastrojejunal ulcer without mention of hemorrhage or perforation, without mention of obstruction

Disease family

This is a subtype of peptic ulcer disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › peptic ulcer disease › gastrojejunal ulcer

Related subtypes (5): gastric ulcer, active peptic ulcer disease, peptic ulcer perforation, duodenal ulcer, peptic esophagitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06543316	Not specified	RECRUITING	Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment